Cite
HARVARD Citation
Cocito, D. et al. (n.d.). Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study. Clinical neurophysiology. 130 (1), pp. e10-. [Online].